HCRN-HOG-08
Phase III Study of Treatment for Aggressive Non-Hodgkin’s Lymphoma – MACOP-B vs CHop
HCRN-HOG-12
A Phase II Trial of VP-16 and Split-Dose Cisplatin in Extensive Small Cell Lung Cancer
HCRN-HOG-11
Phase III Study of Split Dose Cisplatinum Plus VP-16 in the Treatment of Locally Recurrent or Metastatic Non-Small Cell Lung Cancer
HCRN-HOG-03
A Randomized Phase III Study of Variable Length of Treatment on Survival and Duration of Remission in Small Cell Lung Cancer
GI03-53
A Phase II Trial of Preoperative Capecitabine Plus Irinotecan Followed by Combined Modality Capecitabine and Radiation for Locally Advanced Rectal Cancer – GI03-53
HCRN-COE-05
A Retrospective Analysis of Proteomic, Genomic, and Pharmacogenetics in Patients Receiving Systemic Chemotherapy for Locally Advanced or Metastatic Breast Cancer
COE-03
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study
HCRN-COE-02
Department of the Army, US Army Medical Research Acquisition Activity: Center of Excellence for Individualization of Therapy for Breast Cancer: Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study
HCRN-COE-01
Department of the Army, US Army Medical Research Acquisition Activity: Center of Excellence for Individualization of Therapy for Breast Cancer: Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study
HCRN-HOG-09
Phase II Study of Methotrexate, Vinblastine Adriamycin and Cisplatin (M-VAC) Combination Chemotherapy for Previously Untreated or Minimally Treated Advanced Adenocarcinoma of the Breast
HCRN-HOG-07
A Prospective Randomized Controlled Study of Adjuvant Chemotherapy (Cytoxan, Methotrexate, 5-Fluorouracil, Vincristine, Prednisone) vs. No Therapy in Women with ER Negative and Axillary Lymph Node Negative Breast Cancer
HCRN-HOG-04
Phase III Study of Megace vs Aminoglutethimide + Hydrocortisone in Previously Treated Hormonally Responsive Metastatic Breast Cancer
TBCRC012
ABCDE: A Phase II Randomized Study of Adjuvant Bevacizumab, Metronomic Chemotherapy (CM), Diet and Exercise After Preoperative Chemotherapy for Breast Cancer
